Business● Low2h ago · Nov 6, 2026, 11:56 AM
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
GlobeAlert Desk · curated from CNBC · global
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business20m agoDow slides, Nasdaq gains as Wall Street reels from tech selloffSeeking Alpha TechBusiness24m agoUzbekistan announces record cotton harvest as President Mirziyoyev sets higher 2027 yield targetEuroNews [en]Business25m agoFurnaces at ex-ILVA steelworks have been shut downANSA [en]Business25m agoAKITA Drilling Ltd. GAAP EPS of $0.05, revenue of $69.2MSeeking Alpha Tech